ALFA FinderBSE filing, NSE: INSECTICID. Summary written from the filing by ALFA Finder's alert engine.
Insecticides (India) Ltd: key numbers
- Share price
- ₹545.00
- Market cap
- ₹1,586 Cr
- Revenue (annual)
- ₹2,140 Cr
- Net profit (annual)
- ₹139.4 Cr
- P/E (TTM)
- 13.0×Sector 28.2×
- Promoter holding
- 72.30%+0.00% QoQ
- FII holding
- 4.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Insecticides (India) Ltd
All →Insecticides (India) Earnings Call Transcript: Key Takeaways
Q2 revenue rose 8% to ₹686 Cr, but H1 fell 2%, volumes dropped 6-7% and Q2 PAT was ₹56 Cr. Management is upbeat yet hedges on margins, volume recovery and launch timelines.
Insecticides (India) Investor Presentation: Key Takeaways
Q2/H1 FY27 deck; no quarterly revenue, PAT or EBITDA disclosed. Highlights FY23–FY26 margin gains and H1 FY27 field-activity metrics.
Insecticides (India) Results Update
Insecticides (India) released a press release on Q2 and H1 FY27 results. Revenue grew in Q2 while profit after tax declined over the half-year.
Insecticides (India) Dividend
Insecticides (India) declared an interim dividend of Rs.5 per equity share on 5 November 2026 for 2026-2027. Record date is 12 November 2026 and payment is proposed by 17 November 2026.
- Execution
- 2026-2027
Insecticides (India) Q2 FY27 Results: Net Profit ₹56.2 Cr, Down 4.9% YoY
Insecticides (India) Ltd reported revenue from operations of ₹686.3 Cr (+7.6% YoY) and net profit of ₹56.2 Cr (-4.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹56.2 Cr · -4.9% YoY
Insecticides (India) Board Meeting Date
Insecticides (India) will hold a board meeting on November 5, 2026 to consider an interim dividend for FY 2026-27. Record date is fixed as November 12, 2026.
Other product launch announcements
All →AstraZeneca Pharma India Product Launch
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.
Raama Finance Product Launch
Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.
Puravankara Product Launch
Puravankara will launch the residential project Purva Cityspire Phases 1, 2 and 3 in Ernakulam on 15 November 2026. The project is RERA-registered and is being developed by two wholly owned subsidiaries.
JBM Auto Product Launch
JBM Electric Vehicles launched the all-electric ECOLIFE e12 city bus at Singapore Urban Mobility Week 2026. It cites 20,000-bus annual capacity and a new Singapore APAC hub.
- electric bus manufacturing capacity
- 20000.0 buses per annum
Restaurant Brands Asia Product Launch
Burger King India launches a limited-edition Avengers: Doomsday Collection across nationwide restaurants. The menu features themed burgers, sides, and merchandise starting at ₹199.
Hero MotoCorp Product Launch
Hero MotoCorp unveiled new motorcycles at EICMA 2026 and started VIDA customer deliveries across Europe. The company also introduced Novus Labs, its future-mobility innovation hub.